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	 Co(II),	 Ni(II),	 Cu(II)	 and	 Zn(II)	metal	 complexes	 of	 a	 quadridentate	 Schiff	 base	with	 a	 N2S2
donor	set	derived	from	condensation	of	benzene‐1,2‐dicarboxaldehyde(o‐phthaldehyde)	with
2‐aminothiophenol	 were	 synthesized	 and	 characterized	 by	 elemental	 microanalyses,	 molar
conductance,	magnetic	susceptibility	measurements	and	spectroscopic	techniques	viz,	FT‐IR,
1H	 NMR,	 EPR	 and	 UV‐Vis.	 The	 spectral	 data	 showed	 that,	 the	 ligand	 acts	 as	 a	 tetradentate
ligand	 and	 the	 bonding	 sites	 were	 deprotonated	 thiol‐S	 groups	 and	 azomethine	 nitrogen
atoms.	 The	 results	 have	 indicated	 that	 the	 complexes	 exhibited	 tetrahedral	 geometry
arrangements	 except	 Cu(II)	 complex	 that	 exhibited	 square	 planar	 geometry.	 Preliminary
antimicrobial	screening	shows	the	promising	results	against	both	bacterial	and	fungal	strains.
The	 interaction	of	 the	Schiff	 base	 ligand	and	 its	 complexes	with	calf‐thymus	DNA	(CT‐DNA)
has	 been	 monitored	 by	 UV‐Vis,	 competitive	 fluorescence	 titration	 and	 hydrodynamic
techniques	 (Viscosity	 measurements).	 The	 results	 have	 indicated	 that	 the	 ligand	 and	 its
complexes	 bind	 to	 CT‐DNA	 through	 intercalation	 mode.	 Moreover,	 investigations	 of
antioxidative	 properties	 showed	 that	 all	 the	 compounds	 have	 strong	 radical	 scavenging
properties.	 The	 data	 have	 shown	 that,	 among	 all	 compounds,	 Cu(II)	 complex	 has	 exhibited
better	biological	activity	than	other	complexes	and	the	parent	ligand.	KEYWORDS	
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1.	Introduction	
	
In	 recent	 years,	 there	 has	 been	 a	 rapid	 expansion	 in	 the	
development	 of	 metal	 complexes	 as	 extensive	 diagnostic	
agents/chemotherapeutic	drugs	[1].	In	this	regard,	therapeutic	
agents	that	at	pertain	to	less	toxic	and	more	effective	metallic	
component	are	of	particular	interest	and	include	a	plethora	of	
compounds:	 antitumor,	 antioxidant,	 antimicrobial	 and	 anti‐
flammatory	 agents	 [2].	 Nitrogen‐sulfur	 donor	 ligands	 have	
been	 of	 great	 interest	 to	 researchers	 [3].	 The	 presence	 of	
nitrogen	and/or	sulfur	atoms,	provide	these	compounds	with	
the	ability	to	form	metal	complexes	with	heavy	metal	ions	[4].	
The	 fact	 that,	 the	 sulfur	 anion	 formed	 is	 more	 stabilized	 by	
negative	 charge	 distribution	 as	 reported	 [5].	 Schiff	 bases	
containing	N,	 S	donor	atoms	and	 their	metal	 complexes	have	
received	considerable	attention	[6‐9].	Over	the	past	few	years,	
thio‐Schiff	 bases	 and	 their	 metal	 complexes	 have	 received	
considerable	 attention	 in	 the	 field	 of	 coordination	 chemistry	
[10,11].	
Thiosalen	 derivatives	 are	 Schiff	 base	 ligands	 where	 the	
sulfur	 atoms	 are	 substituted	 with	 oxygen	 atoms	 in	 salen	
ligands.	 The	 replacement	 of	 two	 phenoxide	 oxygen	 atoms	 in	
salen	by	two	thiolate	sulfur	atoms	lead	to	changes	in	the	redox	
properties	 of	 the	 corresponding	 complexes.	 Since	 sulfur	 is	 a	
medium‐strength	 soft	 base,	 it	 is	 often	 expected	 that	 coordi‐
nation	 by	 sulfur	will	 stabilize	metals	 in	 low	 oxidation	 states,	
i.e.,	lead	to	a	decrease	in	the	potential	of	the	complex	based	on	
the	 metal	 [12].	 There	 have	 been	 numerous	 transition	 metal	
complexes	containing	salen	and	thiosalen,	with	two	sulfur	and	
two	nitrogen	donor	atoms	(N2S2	donor	set)	[12,13].	
As	 a	 part	 of	 our	 investigation	 on	 Schiff	 bases	 and	 their	
metal	 complexes	 [14‐20],	 we	 have	 recently	 reported	 the	
tetradentate	Schiff	base	N,N'‐bis‐(2‐aminothiophenol)benzene‐
1,2‐dicarboxaldehyde	 (ATBD)	 and	 used	 it	 as	 a	 fluorescence	
sensor	 [19].	 In	 continuation	 of	 our	 work,	 herein,	 we	 have	
synthesized	 Co(II),	 Ni(II),	 Cu(II)	 and	 Zn(II)	 complexes	 of	 the	
novel	 thiosalen	 Schiff	 base	 and	 the	 novel	 compounds	 were	
fully	characterized	by	elemental	analysis,	FT‐IR,	1H	NMR,	EPR,	
electronic	 spectra,	 molar	 conductivity	 and	 magnetic	 suscep‐
tibility	 measurements.	 Moreover,	 the	 interaction	 with	 calf	
thymus	 DNA	 (CT‐DNA),	 antioxidant	 scavenging	 and	 in	 vitro	
antimicrobial	 bacterial	 and	 antifungal	 activities	 of	 the	 novel	
compounds	 were	 investigated	 for	 applications	 in	 biotechno‐
logy	and	medicine.	
190	 Seda	and	Aziz	/	European	Journal	of	Chemistry	6	(2)	(2015)	189‐198	
	
	
 
	
Scheme	1
	
2.	Experimental	
	
2.1.	Materials	
	
2‐Aminothiohenol,	 o‐phthaldehyde,	 Co(OAc)2.4H2O,	
Ni(OAc)2.4H2O,	 Cu(OAc)2.H2O	 and	 Zn(OAc)2.2H2O	 were	
supplied	from	Sigma‐Aldrich.	Calf	 thymus	DNA	(CT‐DNA)	and	
ethidium	bromide	(EB)	were	purchased	from	Sigma	Chemicals	
Co.	All	solvents	used	were	of	analytical	reagent	grade	and	used	
without	further	purification.	
	
2.2.	Instrumentation	
	
Microanalyses	(C,	H	and	N)	were	carried	out	on	a	Perkin‐
Elmer	 240	 elemental	 analyzer.	 The	 FT‐IR	 spectra	 of	 the	
samples	 in	4000‐400	 cm‐1	 region	were	obtained	 in	KBr	discs	
on	 a	 Unicam‐Mattson	 1000	 FT‐IR.	 1H	 NMR	 spectra	 were	
recorded	on	a	Mercury	300	BB	spectrometer	 in	DMSO‐d6	as	a	
solvent.	The	molar	conductivities	of	the	complexes	(1×10‐3	M)	
in	 dimethylsulphoxide	 (DMSO)	 solution	 were	 measured	 at	
room	temperature	by	using	 Jenway	4010	conductivity	meter.	
Room	 temperature	 (298	 K)	 magnetic	 susceptibilities	 were	
measured	 using	 a	 Sherwood	 Scientific	 balance	 using	
Hg[Co(SCN)4]	 as	 a	 calibrant.	Diamagnetic	 corrections	 calcula‐
ted	from	Pascal’s	constants	[21]	were	used	to	obtain	the	molar	
paramagnetic	 susceptibilities.	 The	 X‐band	 EPR	 spectrum	 of	
copper(II)	 complex	 was	 recorded	 at	 room	 temperature	 on	
Bruker	EPR	spectrometer	at	9.706	GHz	(X‐band),	using	DPPH	
as	 the	 g‐marker.	 The	 UV‐Vis	 spectra	 were	 recorded	 on	 a	
Shimadzu	 UV	 1800	 Spectrophotometer,	 equipped	 with	 a	 PC,	
using	 UV	 Probe	 software,	 Ver.	 2.	 Fluorescence	 spectra	 were	
recorded	on	a	Jenway	6270	Fluorimeter	at	room	temperature.	
	
2.3.	Syntheses	
	
2.3.1.	Synthesis	of	N,N'‐bis‐(2‐aminothiophenol)benzene‐
1,2‐dicarboxaldehyde	(ATBD)	
	
The	 Schiff	 base	 ligand	 N,N'‐bis‐(2‐aminothiophenol)	
benzene‐1,2‐dicarboxaldehyde	 (ATBD)	 was	 synthesized	 by	
convenient	method	as	described	previously	[22].	An	ethanolic	
solution	of	2‐aminothiophenol	 (10	mmol)	was	mixed	with	an	
ethanolic	 solution	 of	 o‐phthaldehyde	 (5	 mmol),	 2	 drops	 of	
acetic	 acid	 and	magnetically	 stirred	 in	 a	 round	 bottom	 flask.	
The	 reaction	mixture	was	 then	 refluxed	 for	~5	h	 at	 60	 °C	 in	
water	 bath	 and	 kept	 overnight.	 The	 resulting	 solution	 was	
then	 poured	 into	 crushed	 ice	 water.	 The	 orange	 precipitate	
formed	was	filtered	and	recrystallized	from	hot	methanol	and	
dried	 under	 vacuum	 in	 a	 desiccator	 over	 anhydrous	 CaCl2	 to	
get	 chromatographically	 (TLC)	 pure	 compound.	 Synthetic	
route	of	ATBD	is	shown	in	Scheme	1.	ATBD	(C20H16N2S2):	Yield:	
79%.	FT‐IR	 (KBr,	 ν,	 cm‐1):	2543	 (m,	 S‐H),	1612	 (s,	 C=N),	798	
(m,	C‐S).	 1H	NMR	(300	MHz,	DMSO‐d6,	 δ,	ppm):	3.46	 (s,	2H,	 ‐
SH),	 8.26	 (s,	 2H,	 ‐CH=N),	 6.74‐7.57	 (m,	 12H,	 Ar‐H).	 TOF‐MS	
(m/z):	348	(M+).	Anal.	calcd.	for	C20H16N2S2:	C,	68.93;	H,	4.64;	
N,	8.04,	Found:	C,	68.40;	H,	4.39;	N,	8.00%.	
	
2.3.2.	Synthesis	of	M(II)	complexes	(1‐4)	
	
M(II)	 complexes	 were	 prepared	 by	 using	 the	 following	
general	procedure.	Hot	ethanolic	solution	(10	mL)	of	the	Schiff	
base	 ABTD	 (1	mmol)	 and	 the	metal	 acetate	 salt	 (1	mmol)	 in	
ethanol	 (10	 mL)	 were	 mixed	 thoroughly	 and	 the	 resulting	
solution	was	stirred	and	heated	on	a	hot	plate	at	80	°C	for	4	h.	
The	mixture	was	cooled	to	room	temperature	and	poured	into	
ice	 chilled	 ethanol,	 filtered,	 washed	 several	 times	 with	 hot	
petroleum	 ether	 (60‐80	 °C)	 and	 dried	 under	 vacuum	 in	 a	
desiccator	over	anhydrous	CaCl2.	
Compound	1:	Color:	Green.	Yield:	61%.	FT‐IR	(KBr,	ν,	cm‐1):	
1605	 (s,	 C=N),	 759	 (m,	 C‐S),	 502	 (w,	 Co‐N).	 Anal.	 calcd.	 for	
C20H14N2S2Co:	 C,	 59.25;	H,	 3.48;	N,	 6.91;	 Co,	 14.53.	 Found:	 C,	
57.80,	H,	3.91,	N,	6.52,	Co,	14.37%.	Λm	(−1cm2	mol−1):	3.9.	
Compound	 2:	 Color:	 Brown.	 Yield:	 85%.	 FT‐IR	 (KBr,	 ν,					
cm‐1):	1600	(s,	C=N),	756	(m,	C‐S),	501	(w,	Ni‐N).	Anal.	calcd.	
for	C20H14N2S2Ni:	C,	59.28;	H,	3.48;	N,	6.91;	Ni,	14.48.	Found:	C,	
57.82,	H,	3.92,	N,	6.45,	Ni,	14.39%.	Λm	(−1cm2	mol−1):	9.5.	
Compound	3:	Color:	Green.	Yield:	82%.	FT‐IR	(KBr,	ν,	cm‐1):	
1606	 (s,	 C=N),	 793	 (m,	 C‐S),	 501	 (w,	 Cu‐N).	 Anal.	 calcd.	 for	
C20H14N2S2Cu:	 C,	 58.58;	H,	 3.44;	N,	 6.83;	 Cu,	 15.49.	 Found:	 C,	
57.71,	H,	4.38,	N,	6.12,	Cu,	15.52%.	Λm	(−1cm2	mol−1):	6.5.	
Compound	 4:	 Color:	 Brown.	 Yield:	 77%.	 FT‐IR	 (KBr,	 ν,					
cm‐1):	1608	(s,	C=N),	794	(m,	C‐S),	503	(w,	Zn‐N).	1H	NMR	(300	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 8.26	 (s,	 2H,	 ‐	 CH=N),	 6.99‐7.78	 (m,	
12H,	Ar‐H).	Anal.	calcd.	for	C20H14N2S2Zn:	C,	58.32;	H,	3.42;	N,	
6.80;	Zn,	15.76.	Found:	C,	55.51,	H,	3.36,	N,	6.69,	Zn,	15.76%.	
Λm(−1cm2	mol−1):	4.7.	
	
2.4.	Determination	of	the	metal	content	of	the	complexes	
	
2.4.1.	Determination	of	copper	(II)	
	
An	exact	weight	of	0.1	g	of	Cu(II)	complex	was	dissolved	in	
40	mL	 conc.	HNO3.	 The	 solution	was	 boiled	 to	 evaporate	 the	
acidic	 solution	 near	 dryness,	 add	 another	 amount	 of	 conc.	
HNO3	 and	 evaporated.	 This	 process	 was	 repeated	 several	
times	 then	 diluted	 by	 distilled	 water.	 The	 resultant	 solution	
was	 filtered	 to	 remove	 the	 precipitated	 ligand.	 Ammonium	
hydroxide	 solution	 was	 then	 added	 to	 neutralize	 the	 acidic	
solution	 and	 transferred	 to	 50	 mL	 measuring	 flask	 and	
completed	with	deionized	water.	5	ml	of	the	solution	was	then	
titrated	 with	 0.01	 M	 EDTA	 solution	 using	 murexide,	 as	 an	
indicator,	to	determine	the	end	point,	which	was	characterized	
by	a	colour	change	from	yellow	to	orange	[23].	
	
2.4.2.	Determination	of	nickel	(II)	
	
An	exact	weight	of	0.1	g	of	Ni(II)	complex	was	treated	in	a	
similar	 manner	 to	 the	 previous	 one.	 Ammonium	 hydroxide	
was	 also	 added	 until	 the	 nickel	 ions	 were	 converted	 to	 the	
nickel	tetramine	complex,	which	was	judged	by	colour	change	
from	green	to	blue.	Murexide	was	then	added	as	an	indicator	
and	the	solution	was	titrated	with	0.01	M	EDTA	solution.	The	
end	 point	 was	 detected	 by	 a	 colour	 change	 from	 orange	 to	
purple	[24].	
	
2.4.3.	Determination	of	cobalt	(II)	
	
An	exact	weight	of	0.1	g	of	Co(II)	complex	was	treated	in	a	
similar	manner	to	the	previous	one.	To	the	cobalt	(II)	solution	
0.1	M	sodium	acetate	was	added	followed	by	murexide,	as	an	
indicator,	ammonium	hydroxide	solution	was	added	until	 the	
colour	 changes	 from	 orange	 to	 yellow.	 The	 solution	 was	
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titrated	 with	 0.01	 M	 EDTA	 solution.	 The	 end	 point	 was	
detected	by	a	colour	change	from	yellow	to	deep	purple	[24].	
	
2.4.4.	Determination	of	zinc	(II)	
	
An	exact	weight	of	0.1	g	of	Zn(II)	complex	was	dissolved	in	
40	mL	conc.	HNO3.	The	acidic	solution	was	treated	in	the	same	
manner	 as	 the	 previous	 ones.	 In	 a	 conical	 flask,	 5	mL	 of	 the	
solution	were	used	for	every	titration.	5	mL	of	ammonia	buffer	
solution	 (pH	=	10)	and	5	drops	0.1	%	of	Eriochrome	Black	T	
(EBT)	were	then	added.	The	solution	was	titrated	with	0.01	M	
EDTA	solution.	The	end	point	was	detected	by	a	colour	change	
from	wine	red	to	blue	[25].	
	
2.5.	Antimicrobial	screening	
	
Antimicrobial	activities	of	the	synthesized	compounds	are	
investigated	 using	 agar	 well	 diffusion	 method	 [26].	
Antibacterial	 activities	 are	 investigated	 against	 bacteria	
strains	 Staphylococcus	 aureus,	 Pseudomonas	 aeruginosa,	
Escherichia	 coli,	 and	 Staphylococcus	 epidermidis,	 whereas	
Aspergillus	 niger,	 Aspergillus	 flavus,	 Culvularia	 lunata	 and	
Candida	 albicansare	 used	 to	 test	 antifungal	 activities.	 The	
tested	 compounds	 were	 dissolved	 in	 DMSO	 (which	 has	 no	
inhibition	activity),	to	get	concentration	of	1	mg/mL.	The	test	
was	performed	on	potato	dextrose	agar	(PDA)	medium,	which	
contains	infusion	of	200	g	potatoes,	6	g	dextrose	and	15	g	agar.	
Uniform	 size	 filter	 paper	 disks	 (three	 disks	 per	 compound)	
were	 impregnated	by	equal	volume	(10	μL)	 from	the	specific	
concentration	 of	 dissolved	 test	 compounds	 and	 carefully	
placed	on	incubated	agar	surface.	After	incubation	for	36	h	at	
27	 °C	 in	 the	case	of	bacteria	and	48	h	 at	24	 °C	 in	 the	case	of	
fungi,	 inhibition	 of	 the	 organisms	 which	 evidenced	 by	 clear	
zone	surround	each	disk	was	measured	and	used	to	calculate	
mean	 of	 inhibition	 zones.	 Streptomycin	 and	 Nystatin	 were	
used	 as	 standard	 reference	 in	 the	 case	 of	 bacteria	 and	
antifungal	studies,	respectively.	
	
2.6.	DNA‐binding	studies	
	
Concentrated	 CT‐DNA	 stock	 solution	 was	 prepared	 in	 5	
mM	tris‐Cl/50	mM	NaCl	in	water	at	pH	=	7.5	and	stored	at	4	°C	
and	 were	 used	 within	 four	 days.	 The	 concentration	 of	 DNA	
solution	 was	 determined	 by	 UV	 absorbance	 at	 260	 nm	 (ɛ	 =	
6600	M‐1·cm‐1)	 [27].	Solution	of	CT‐DNA	in	5	mM	tris‐HCl/50	
mM	NaCl	(pH	=	7.5)	gave	a	ratio	of	UV	absorption	at	260	nm	
and	280	nm	A260/A280	of	~1.8‐1.9,	indicating	that	the	DNA	was	
sufficiently	 free	 of	 protein	 [28].	 In	 order	 to	 study	 the	
interaction	of	CT	DNA	with	the	compounds,	they	were	initially	
dissolved	in	DMSO	to	obtain	concentration	of	(1	mM).	Mixing	
of	such	solutions	with	the	aqueous	buffer	solutions	used	in	the	
studies	 never	 exceeded	 5%	DMSO	 (v:v)	 in	 the	 final	 solution,	
which	was	needed	due	to	low	aqueous	solubility	of	complexes.	
All	studies	were	performed	at	room	temperature.	
The	 interaction	 of	 ATBD	 and	 its	 complexes	1‐4	with	 CT‐
DNA	 has	 been	 studied	 with	 UV	 spectroscopy	 in	 order	 to	
investigate	 the	 possible	 binding	 modes	 to	 CT‐DNA	 and	 to	
calculate	the	binding	constants	(Kb).	The	UV	spectra	of	CT‐DNA	
in	 the	 presence	 of	 each	 compound	have	 been	 recorded	 for	 a	
constant	 CT‐DNA	 concentration	 in	 diverse	mixing	 ratios	 (r	 =	
[Compound]/[CT‐DNA]).	 The	 binding	 constants	 of	 the	
compounds	with	CT‐DNA,	Kb,	have	been	determined	using	the	
UV	 spectra	 of	 the	 complexes	 recorded	 for	 a	 constant	
concentration	 in	 the	 absence	 or	 presence	 of	 CT‐DNA	 for	
diverse	 r	 values.	 Control	 experiments	 with	 5%	 DMSO	 were	
performed	 and	 no	 changes	 in	 the	 spectra	 of	 CT‐DNA	 were	
observed.	 The	 absorption	 titrations	 of	 the	 compounds	 were	
performed	using	a	fixed	concentration	(25	μM)	for	compound	
to	which	increments	of	the	CT‐DNA	stock	solution	were	added.	
The	 interacted	 solutions	were	 allowed	 to	 incubate	 for	 5	min	
before	 the	 absorption	 spectra	 were	 recorded.	 The	 intrinsic	
binding	constants	Kb,	based	on	 the	absorption	 titration,	were	
measured	 by	 monitoring	 the	 changes	 of	 absorption	 with	
increasing	 concentration	 of	 CT‐DNA	 using	 the	 following	
Equation	(1):	
	
	
	
	
	 	
	
		 	 	 (1)	
	
where	[CT‐DNA]	is	the	concentration	of	DNA	in	base	pairs,	the	
apparent	 absorption	 coefficients	 εa,	 εf	 and	 εb	 correspond	 to	
Aobs/[Complex],	extinction	coefficient	for	the	free	complex	and	
the	 extinction	 coefficient	 of	 the	 complex	 in	 the	 totally	 bound	
form,	respectively.	The	data	were	fitted	to	Equation	(1),	with	a	
slope	equal	to	1/(εa‐εf)	and	y‐intercept	equal	to	1/Kb(εb‐εf)	and	
Kb	was	obtained	from	the	ratio	of	the	slope	to	the	intercept.	
The	 competitive	 studies	 of	 each	 complex	 with	 EB	 have	
been	 investigated	 by	 fluorescence	 spectroscopy	 in	 order	 to	
examine	 whether	 the	 complex	 can	 displace	 EB	 from	 its	 EB‐
CTDNA	 complex.	 The	 EB‐CT‐DNA	 complex	 was	 prepared	 by	
adding	20	μM	EB	and	40	μM	CT‐DNA	in	buffer	(150	mM	NaCl	
and	15	mM	trisodium	citrate	at	pH	=	7.0).	The	solutions	were	
excited	at	540	nm	and	fluorescence	emission	at	598	nm,	were	
recorded.	The	samples	were	shaken	and	kept	 for	2‐3	min	 for	
equilibrium	 and	 then	 the	 spectra	 were	 recorded.	 The	
intercalating	 effect	 of	 the	 complexes	 with	 the	 EB‐CT‐DNA	
complex	was	studied	by	adding	a	certain	amount	of	a	solution	
of	 the	compound	step	by	step	 into	 the	solution	of	 the	EB‐CT‐
DNA	 complex.	 The	 influence	 of	 the	 addition	 of	 each	 complex	
was	 monitored	 in	 the	 range	 of	 560‐700	 nm.	 Commonly,	
fluorescence	 quenching	 can	 be	 described	 by	 the	 following	
Stern‐Volmer	(Equation	2)	[29]:	
	
	1	 	 	 	 	 	 (2)	
	
where	 I0	and	I	are	the	steady‐state	fluorescence	intensities	 in	
the	absence	and	presence	of	quencher	(Q),	respectively.	Ksv	 is	
the	Stern‐Volmer	quenching	constant,	obtained	from	the	slope	
of	the	plot	of	I0/I	versus	[Q].	
Hydrodynamic	measurements,	 i.e.	 viscosity	 and	 sedimen‐
tation	that	are	sensitive	to	length	changes	are	regarded	as	the	
least	ambiguous	and	most	critical	 tests	 to	a	binding	model	 in	
solution	in	the	absence	of	crystallographic	structural	data	[30].	
Viscosity	measurements	were	 carried	 out	 using	 an	Ostwald’s	
capillary	viscometer,	immersed	in	a	thermo	stated	water	bath	
with	 the	 temperature	 setting	 at	 25±0.1	 °C.	 CT‐DNA	 samples	
with	 an	 approximate	 average	 length	 of	 200	 base	 pairs	 were	
prepared	 by	 sonication	 in	 order	 to	 minimize	 complexities	
arising	 from	 DNA	 flexibility	 [31].	 Titrations	 were	 performed	
for	 the	 studied	 compounds	 (0.0‐5.0	 μM),	 where	 each	
compound	was	introduced	into	a	CT‐DNA	solution	(0.30	mM)	
present	in	the	viscometer.	The	flow	times	were	measured	with	
a	 digital	 stopwatch.	 Each	 sample	 was	measured	 three	 times	
and	 an	 average	 flow	 time	 was	 recorded.	 The	 data	 were	
presented	as	(η/ηo)1/3	vs	[Compound]/[DNA]	ratio	[32],	where	
η	and	ηo	are	the	viscosity	of	DNA	in	the	presence	and	absence	
of	the	studied	compounds,	respectively.	The	values	of	η	and	ηo	
were	calculated	by	Equation	(3):	
	
η 		 	 	 	 	 (3)	
	
where	 t	 is	 the	 observed	 flow	 time	 of	 CT‐DNA	 containing	
solution	 and,	 to	 is	 the	 flow	 time	 of	 buffer	 alone.	 Relative	
viscosities	for	CT‐DNA	were	calculated	from	the	relation	η/ηo.	
	
2.7.	Antioxidant	assays	
	
2.7.1.	Superoxide	radicals	scavenging	assay	
	
The	superoxide	 radicals	 (O2−•)	were	generated	 in	 the	 test	
system	 using	 NBT/VitB2/MET	 and	 determined	 spectro‐
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metrically	 by	 nitrobluetetrazolium	 photo	 reduction	 method	
[33‐35].	The	suppression	of	superoxide	radicals	was	calculated	
by	measuring	 the	absorbance	at	560	nm.	ATBD	and	 its	metal	
complexes	 (5‐25	 μM)	 were	 added	 to	 a	 solution	 containing	
[NBT	 (65	 μM),	 L‐MET	 (13	 mM),	 VitB2	 (1.5	 μM),	 EDTA	 (0.1	
mM)]	 and	 the	 resulting	 solution	was	made	 up	 to	 2	mL	with	
phosphate	 buffer	 (10	 mM,	 pH	 =	 7.0)	 in	 dark.	 The	 above	
mixture	was	 illuminated	with	 a	white	 fluorescence	 lamp	 (15	
W)	 for	15	min	and	 the	absorbance	(Ai)	was	measured	at	560	
nm.	The	above	mixture	containing	no	investigated	compounds	
was	used	as	a	control	and	its	absorbance	was	taken	as	A0.	All	
the	 experiments	 were	 conducted	 in	 triplicate	 and	 data	were	
expressed	as	the	mean	value.	The	suppression	ratio	for	(O2−•)	
was	calculated	by	using	following	equation.	
	
O. 	Scavenging	activity	 % 	 	 	x	100	 	 (4)	
	
The	 antioxidant	 activity	 was	 expressed	 as	 the	 50%	
inhibitory	 concentration	 (IC50).	 IC50	 values	 were	 calculated	
from	 regression	 lines	 where;	 x	 was	 the	 tested	 compound	
concentration	in	μM	and	y	was	percent	inhibition	of	the	tested	
compounds.	
	
2.7.2.	Hydroxy	radical	scavenging	activity	
	
The	 hydroxyl	 radicals	 (HO•)	 in	 aqueous	 media	 were	
generated	through	the	Fenton	system	[35].	The	solution	of	the	
tested	compound	was	prepared	with	DMSO.	An	assay	mixture	
(5	mL)	 contained	 the	 following	 reagents:	 safranin	 (11.4	 μM),	
EDTA‐Fe(II)	(40	μM),	H2O2	(0.6%),	the	tested	compound	(5‐25	
μM)	 and	 a	 phosphate	 buffer	 (67	 mM,	 pH	 =	 7.4).	 The	 assay	
mixtures	were	 incubated	at	45	 	for	50	min	in	a	water‐bath,	
and	then	the	absorbance	(Ai,	Ao	and	Ac)	were	measured	at	520	
nm.	 All	 the	 tests	were	 run	 in	 triplicate	 and	 expressed	 as	 the	
mean	 value.	 The	 suppression	 ratio	 for	 (HO·)	 was	 calculated	
from	the	following	expression:	
	
HO.Supression	ratio	 % 	 	
	
	 100	 	 (5)	
	
where	 Ai	 =	 the	 absorbance	 in	 the	 presence	 of	 the	 tested	
compound;	 Ao	 =	 the	 absorbance	 in	 the	 absence	 of	 the	 tested	
compound;	 Ac	 =	 the	 absorbance	 in	 the	 absence	 of	 the	 tested	
compound,	EDTA‐Fe(II)	and	H2O2.	The	antioxidant	activity	was	
expressed	 as	 the	 50%	 inhibitory	 concentration	 (IC50).	 IC50	
values	were	calculated	from	regression	lines	where;	x	was	the	
tested	 compound	 concentration	 in	 μM	 and	 y	 was	 percent	
inhibition	of	the	tested	compounds.	
	
3.	Results	and	discussion		
	
The	 tetradentate	 Schiff	 base	 ligand,	 namely	 N,N'‐bis‐(2‐
aminothiophenol)benzene‐1,2‐dicarboxaldehyde	 (ATBD)	 was	
obtained	 by	 employing	 condensation	 reaction	 of	 o‐
phthaldehyde	 (1	 mmol)	 with	 2‐aminothiophenol	 (2	 mmol)	
under	thermal	condition.	It	is	apparent	that	the	ligand	exhibit	
a	considerable	reactivity	towards	M(II)	transition	metals	(M	=	
Co(II),	Ni(II),	Cu(II)	and	Zn(II)),	affording	solid	products	which	
are	 fairly	 stable	 in	 air	 and	 moisture.	 The	 ligand	 and	 its	
complexes	 have	 been	 fully	 characterized	 by	micro	 elemental	
analysis	 and	 different	 spectroscopic	 techniques.	On	 the	 basis	
of	 elemental	 analyses,	 the	 Schiff	 base	 behaves	 as	 neutral	
tetradentate	chelate	with	N2S2	donor	atoms	and	the	complexes	
are	 suggested	 to	 have	 1:1	 stoichiometry.	 The	 ligand	 and	 its	
complexes	 are	 freely	 soluble	 in	 dichloromethane	 (DCM),	
tetrahydrofuran	 (THF),	 dimethylformamide	 (DMF)	 and	
dimethyl	 sulfoxide	 (DMSO).	 The	 molar	 conductivities	 of	
complexes	 in	DMSO	(1×10‐3	M	solutions)	 indicate	 that	all	 the	
metal	complexes	have	conductivity	values	 in	accordance	with	
non‐electrolytes	nature	[36].	
	
3.1.	Infrared	spectra	
	
The	 mode	 of	 binding	 of	 the	 Schiff	 base	 (ATBD)	 to	 M(II)	
ions	 was	 elucidated	 by	 comparing	 the	 FT‐IR	 spectra	 of	 the	
complexes	with	that	of	the	free	ligand.	The	FT‐IR	spectrum	of	
parent	 Schiff	 base	 ligand	 show	 some	 main	 characteristic	
features,	the	first	one	is	the	appearance	of	the	intense	band	at	
1612	 cm‐1,	 which	 is	 assigned	 to	 ν(C=N)	 (azomethine	 moiety),	
indicating	 the	 formation	 of	 the	 Schiff	 base	 [37],	 while	 the	
second	 feature	 is	 the	 appearance	 of	medium	 intense	 band	 at	
2543	cm‐1,	which	 is	attributed	 to	ν(S‐H).	On	comparison	 to	 the	
parent	 Schiff	 base	 ligand,	 upon	 complex	 formation,	 the	 ν(C=N)	
band	 is	 shifted	 towards	 lower	 frequencies	 in	 the	 spectra	 of	
metal	complexes	(1600‐1608	cm‐1)	indicating	the	involvement	
of	 the	 azomethine	 nitrogen	 in	 coordination	 with	 metal	 ion	
[38].	 Furthermore,	 the	 disappearance	 of	 the	 ν(S‐H)	 upon	
complexation	 was	 an	 indicative	 of	 deprotonation	 prior	 to	
coordination	 through	 the	 sulfur	 atom	 in	 all	 the	 complexes.	
Moreover	the	shift	ν(C–S)	band	of	ATBD	at	798	cm‐1	to	749‐694	
cm‐1	 in	 these	 complexes	 confirm	 the	 participation	 of	 thiol	
sulfur	on	chelation	[39].	Conclusive	evidence	of	the	bonding	is	
also	shown	by	the	observation	that	new	bands	in	the	spectra	of	
all	metal	complexes	appearing	in	the	low	frequency	regions	at	
501‐503	cm‐1	which	are	characteristic	to	the	ν(M‐N)	 [10].	Thus,	
the	 FT‐IR	 spectral	 data	 provide	 strong	 evidences	 for	 the	
complexation	 of	 the	 tetradentate	 Schiff	 bases	 with	 SNNS	
sequence.	
	
3.2.	1H	NMR	studies	of	ATBD	and	its	Zn(II)	complex	
	
Evidence	 for	 the	 bonding	 mode	 of	 the	 ligand	 (ATBD)	 is	
provided	also	by	the	1H	NMR	spectra	of	the	Schiff	base	and	the	
diamagnetic	Zn(II)	complex	which	were	recorded	in	DMSO‐d6	
at	 room	 temperature	 showed	 a	 sharp	 singlet	 signal	 at	 8.26	
ppm,	assigned	to	the	azomethine	hydrogen	atom.	The	shift	of	
the	 imine	 carbon	proton	 signal	 to	 downfield	 region	 in	 Zn(II)	
complex	 in	 comparison	with	 that	 of	 the	 free	 ligand	 inferred	
coordination	 through	 the	 azomethine	 nitrogen	 atom	 of	 the	
ligand.	 The	multiplet	 signals	 due	 to	 the	 aromatic	 protons,	 in	
ATBD	 in	 the	 range	 6.74‐7.57	 ppm	 exhibited	 a	 shift	 in	 Zn(II)	
complex	 at	 6.99‐7.78	 ppm,	 which	 may	 be	 attributed	 to	 the	
changes	 in	 the	 electronic	 environment	 around	 the	 protons	
attached	 to	 the	 group	 that	 contain	 the	 site	 of	 donation	 and	
involvement	in	complexation	[40].	Furthermore,	a	comparison	
of	 1H	 NMR	 spectrum	 of	 diamagnetic	 Zn(II)	 complex	 showed	
that,	 the	 singlet	 signal	 at	 δ	 3.46	 ppm,	 assigned	 to	 thiol‐SH	
protons	was	missed.	 The	 absence	 of	 ‐SH	 signal	 indicated	 the	
participation	 of	 thiol	 SH	 group	 in	 chelation	 with	 proton	
displacement	and	confirmed	the	bonding	of	sulfur	to	the	metal	
ions	(C‐S‐M).	
	
3.3.	Magnetic	moments	and	electronic	spectral	analysis	
	
Magnetic	 measurements	 and	 electronic	 spectra	 were	
recorded	at	room	temperature	 in	order	to	obtain	 information	
about	 the	 geometry	 of	 the	 complexes.	 Electronic	 spectra	 of	
ATBD	and	its	complexes	were	recorded	in	DMSO	(1×10‐5	M)	in	
the	range	200‐800	nm.	The	UV‐visible	spectrum	of	free	ATBD	
exhibit	 two	 intense	 bands	 at	 289	 and	 350	 nm,	 assigned	 to	
intraligand	 (IL)	 π‐π*	 and	 n‐π*	 of	 benzene	 and	 non‐bonding	
electrons	present	on	the	nitrogen	of	the	azomethine	moiety.	In	
the	 complexes	 spectra,	 the	 ‐*	 and	 n‐*	 transitions	
experiences	some	shift	due	 to	coordination	of	 imino	nitrogen	
atom	moiety.	Co(II)	complex	1	showed	a	magnetic	moment	of	
4.62	 B.M.,	 suggesting	 four‐tetrahedral	 geometry.	 The	
electronic	 spectra	 of	 the	 Co(II)	 complex	 1	 showed	 an	
absorption	 band	 at	 624	 nm	 assignable	 to	 4A2(F)	 →	 4T1(P),	
which	 is	 characteristic	 value	 for	 the	 tetrahedral	 Co(II)	
complex.	 The	 observed	 magnetic	 moment	 of	 Ni(II)	 complex	
was	3.23	B.M.	which	 indicated	 the	non‐coupled	mononuclear	
complex	 of	 d8	 system	 with	 s	 =	 1	 spin	 state	 of	 tetrahedral	
geometry	[41,42].	
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Table	1.	Magnetic	moment	values	and	electronic	absorption	spectral	data	of	Schiff	base	(ATBD)	its	complexes	1‐4.	
Compound	 μeff	(B.M)	 λmax	(nm)	 Assignments	 Geometry	
ATBD	 ‐	 289	
350	
→*	
n→*	
‐	
[C20H14N2S2Co]	(1)	 4.62	 290	
345	
624	
→*	
n→*	
4A2(F)	→	4T1(P)	
Tetrahedral	
[C20H14N2S2Ni]	(2)	 3.23	 286	
355	
532	
692	
→*	
n→*	
3T1(F)	→	3T1(P)	
3T1(F)	→	3A2(F)	
Tetrahedral	
[C20H14N2S2Cu]	(3)	 1.73	 279	
344	
457	
647	
→*	
n→*	
2B1g	→	2Eg	
2B1g	→	2A1g	
Square	planar	
[C20H14N2S2Zn]	(4)	 ‐	 280	
344	
402	
→*	
n→*	
MLCT	
Tetrahedral	
	
	
																																																												 	
	
	
M	=	Co(II),	Ni(II)	and	Zn(II)
	
													M =	Cu(II)
Scheme	2
	
	
The	electronic	absorption	of	 the	Ni(II)	complex	2	showed	
two	bands	in	the	visible	region	at	692	and	532	nm	which	are	
assigned	 to	 3T1(F)	 →	 3A2(F)	 (ν2)	 and	 3T1(F)	 →	 3T1(P)	 (ν3)	
transitions,	 respectively	 suggesting	 a	 tetrahedral	 geometry	
around	Ni(II)	 ion.	On	 the	 other	 hand,	 the	 observed	magnetic	
moments	 (μeff)	of	Cu(II)	 complex	3	 at	 room	temperature	was	
1.73	 B.M.,	 which	 was	 consistent	 with	 presence	 of	 a	 single	
unpaired	electron	 [43]	and	suggesting	 that	 the	square‐planar	
geometry	[44].	The	electronic	spectrum	of	the	Cu(II)complex	3	
showed	 two	bands	at	about	647	and	457	nm	which	could	be	
assigned	to	2B1g	→	2A1g	and	2B1g	→	2Eg	transitions,	respectively	
[44],	indicating	the	square	planar	geometry	for	Cu(II)	complex.	
Finally,	 the	 electronic	 spectrum	 of	 the	 Zn(II)	 complex	 4	
showed	 one	 high‐intensity	 band	 at	 402	 nm,	 which	 was	
assigned	 to	metal‐to‐ligand	 charge	 transfer	 [45].	 It	 is	 known	
that	 the	 Zn(II)	 complex	 is	 diamagnetic	 as	 expected	 for	 a	 d10	
configuration	and	on	 the	basis	of	analytical,	 conductance	and	
infrared	spectral	data,	a	tetrahedral	geometry	is	proposed	for	
the	Zn(II)	 complex.	The	electronic	 spectral	data	of	ATBD	and	
its	 complexes	 along	 with	 magnetic	 moment	 values	 with	
tentative	 assignments	 are	 summarized	 in	 Table	 1.	 Based	 on	
the	 above	 spectral	 data	 expected	 structures	 for	 the	prepared	
complexes	were	presented	in	Scheme	2.	
	
3.4.	EPR	spectral	studies	
	
EPR	 studies	 of	 paramagnetic	 transition	 metal	 complexes	
give	 information	 about	 the	 distribution	 of	 the	 unpaired	
electrons	and	hence	about	the	nature	of	the	bonding	between	
the	metal	ion	and	its	ligand	[46].	The	X‐band	EPR	spectrum	of	
Cu(II)	 complex	 was	 recorded	 in	 the	 solid	 state	 at	 room	
temperature	 (Figure	 1).	 The	 Cu(II)	 complex	 exhibit	 typical	
axial	 behavior	 with	 slightly	 different	 g||	 and	 g	 values.	 For	
Cu(II)	 complex	 at	 room	 temperature,	 g||=	 2.09076,	 g	 =	
2.06345	and	gav=	2.08165.	The	g||	>	g 	>	2.0023	indicates	that	
the	unpaired	electron	is	present	in	the	dx2‐y2	ground	state	in	a	
square	planar	geometry	[47].	Moreover,	g||	<	2.3	value	suggests	
covalent	 character	 of	 the	 metal‐ligand	 bond	 [48].	 This	 is	
further	 supported	 by	 calculating	 the	 axial	 symmetry	
parameter	 (G),	 which	 is	 a	 measure	 of	 exchange	 coupling	
interaction	between	two	Cu(II)	ions	using	Kneubuhl’s	method	
[49],	G	=	(g‖‐2.0023)/(g‐2.0023).	According	to	Hathaway	[50],	
if	 the	G	value	was	>	4,	 the	 exchange	 interaction	 is	negligible,	
while	 a	 value	 of	 <	 4	 indicated	 a	 considerable	 exchange	
interaction	in	the	complex.	The	axial	symmetry	parameter	(G)	
of	 Cu(II)	 complex	 was	 1.4466	 indicating	 considerable	
exchange	 interaction	 in	 the	 solid	 complexes	 [51].	 Thus,	 the	
EPR	study	of	Cu(II)	complex	has	provided	supportive	evidence	
to	the	conclusion	obtained	on	the	basis	of	electronic	spectrum	
and	magnetic	moment	value.	
	
	
	
Figure	1.	EPR	spectrum	of	Cu(II)	complex	at	room	temperature.
	
3.5.	Bioactivity	evaluation	
	
Thiol	 containing	 compounds	 play	 an	 important	 role	 in	
protecting	biological	systems	against	oxidative	injury.	There	is	
also	 increasing	 evidence	 for	 thiol	 involvement	 in	 metabolic	
regulation,	 signal	 transduction	 and	 regulation	 of	 gene	
expression	[52].	Physiological	thiols	vary	substantially	in	their	
reactivity,	 and	on	 this	basis,	 thiol	 groups	would	be	preferred	
cellular	targets	for	various	oxidants	[53].	
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3.5.1.	Antimicrobial	activity	
	
The	 Schiff	 base	 complexes	 have	 provoked	 wide	 interest	
because	 they	 possess	 a	 diverse	 spectrum	 of	 biological	 and	
pharmaceutical	 activities.	 Consequently,	 the	 antibacterial	
activity	of	the	Schiff	base	ligand	and	its	metal	complexes	were	
tested	against	bacteria	because	bacteria	can	achieve	resistance	
to	 antibiotics	 through	 biochemical	 and	 morphological	
modifications	 [54].	 The	 bacteria	 strains	 used	 in	 the	 present	
investigation	 included	 S.	 aureus,	 P.	 aeruginosa,	 E.	 coli,	 S.	
epidermidis.	 Furthermore,	 the	 synthesized	 Schiff	 base	 and	 its	
metal	 complexes	were	 screened	 in	 vitro	 in	 order	 to	 find	 out	
the	 antifungal	 activity	 against	 the	 fungi	 strains	 A.	 niger,	 A.	
flavus,	C.	lunata	and,	C.	albicans.	The	results	of	the	antibacterial	
and	antifungal	activities	are	graphically	represented	in	Figure	
2.	 The	 results	 of	 antibacterial	 and	 antifungal	 reveals	 that	 the	
metal	 complexes	 are	 toxic	 than	 the	 free	 ligand	 against	 the	
same	 organisms.	 It	 is	 suggested	 that	 the	 complexes	 having	
antibacterial	 and	 antifungal	 activities	 through	 inhibition	
multiplication	process	of	the	microbe	by	blocking	their	active	
sites	 [55].	 The	mechanism	 of	 toxic	 activity	 of	 the	 complexes	
relative	 to	 the	 ligand	 can	 be	 ascribed	 to	 the	 increase	 in	 the	
lipophilic	 nature	 of	 the	 complexes	 arising	 from	 chelation.	
Chelation	 reduces	 the	 polarity	 of	 the	 metal	 atom	 mainly	
because	of	partial	sharing	of	its	positive	charge	with	the	donor	
groups	and	possible	‐electron	delocalization	within	the	whole	
chelate	 ring.	 Moreover,	 the	 chelation	 also	 increases	 the	
lipophilic	nature	of	the	metal	atom,	which	subsequently	favors	
the	permeation	through	the	 lipid	 layer	of	cell	membrane.	The	
mode	 of	 action	 of	 complexes	 involves	 the	 formation	 of	
hydrogen	 bonds	 with	 the	 imino	 group	 by	 the	 active	 sites	
leading	 to	 interference	 with	 the	 cell	 wall	 synthesis.	 This	
hydrogen	bond	formation	damages	the	cytoplasmic	membrane	
and	 the	 cell	 permeability	may	 also	 be	 altered	 leading	 to	 cell	
death	[56].	
	
3.5.2.	DNA	binding	studies	
	
It	 is	 a	 well‐known	 fact	 that	 CT‐DNA	 is	 the	 primary	
pharmacological	 target	 of	 many	 antitumor	 compounds,	 and	
hence	the	interaction	between	CT‐DNA	and	metal	complexes	is	
of	 paramount	 importance	 in	 understanding	 the	 mechanism.	
Thus,	 the	mode	and	propensity	 for	binding	of	 the	complex	 to	
CT‐DNA	 were	 studied	 with	 the	 aid	 of	 different	 techniques.	
Monitoring	the	changes	in	the	absorption	spectra	of	ATBD	and	
its	complexes	1‐4	upon	addition	of	increasing	amounts	of	CT‐
DNA	is	one	of	the	most	widely	used	methods	for	determining	
the	 overall	 binding	 constants.	 Upon	 the	 addition	 of	 CT‐DNA,	
hyperchromism	and	hypochromism	in	the	absorbencies	of	the	
d‐d	 transition	 absorption	 bands	 of	 the	 complexes	 were	
observed	 [57].	 The	 extent	 of	 the	 hypochromism	 commonly	
parallels	 the	 intercalative	 binding	 strength	 [58].	 The	
hypochromicity,	 characteristic	 of	 intercalation	 has	 been	
usually	 attributed	 to	 the	 interaction	 between	 the	 electronic	
states	 of	 the	 compound	 chromophores	 and	 those	 of	 the	 CT‐
DNA	 bases	 [59],	 while	 the	 hyperchromicity	 (red	 shift)	 has	
been	associated	with	the	decrease	in	the	energy	gap	between	
the	 highest	 and	 the	 lowest	 molecular	 orbitals	 (HOMO	 and	
LUMO)	after	binding	of	the	complex	to	CT‐DNA	[60].	
Absorption	 titration	 experiments	 were	 performed	 by	
maintaining	the	studied	compounds	concentration	as	constant	
at	25	μM	while	varying	the	concentration	of	the	DNA	within	0‐
50	μM	(Figure	3).	As	shown	in	Figure	3,	it	was	obviously	that,	a	
significant	hypochromism	with	a	red	shift	of	3,	8,	5,	14	and	4	
nm	 for	ATBD	 and	 its	 complexes	1‐4,	 respectively,	 suggesting	
strong	binding	to	CT‐DNA	in	an	intercalative	mode.	In	order	to	
compare	quantitatively,	the	binding	strength	with	CT‐DNA,	the	
intrinsic	 binding	 constants	 Kb	 of	 the	 reported	 compounds	
(Figure	3	 insets)	were	determined.	The	Kb	values	were	found	
to	 be	 (5.82±0.15)×104	 M‐1,	 (8.78±0.35)×105	 M‐1,	 (2.51±0.28)	
×105	 M‐1,	 (4.17±0.13)×106	 M‐1	 and	 (1.55±0.10)×105	 M‐1	 for	
ATBD	 and	 its	 complexes	 1‐4,	 respectively.	 These	 values	
indicated	that,	 the	order	of	binding	affinity	 is	3	>	1	>	2	>	4	>	
ATBD.	The	Kb	values	of	complexes	are	higher	than	that	of	the	
classical	 intercalator	 EB	 (Kb	 =	 (1.23±0.07)×105	 M‐1)	 [61],	
which	may	be	a	first	evidence	of	the	ability	of	the	compounds	
to	displace	EB	 in	 the	case	of	 intercalation	except	ATBD	Schiff	
base	 ligand.	 An	 explanation	 for	 higher	 Kb	 value	 of	 Cu(II)	
complex	is	apparently	that	copper	is	 ‘borderline’	metal	which	
show	high	affinity	for	both	nucleobases	and	phosphate	[62].	
	
(a)	
	
(b)	
Figure	2.	Biological	 diagram	of	 Schiff	 base	 (ATBD)	 and	 its	 complexes	1‐4	
against	(a)	bacteria	strains	and	(b)	fungi	strains.	
	
Ethidium	 bromide	 (EB	 =	 3,8‐diamino‐5‐ethyl‐6‐phenyl	
phenanthridinium	bromide)	emits	 intense	fluorescence	in	the	
presence	of	 CT‐DNA	as	 a	 result	 of	 strong	 intercalation	of	 the	
planar	EB	phenanthridine	ring	between	adjacent	base	pairs	on	
the	double	helix;	therefore,	EB	is	considered	a	typical	indicator	
of	intercalation	[63].	The	changes	observed	in	the	fluorescence	
emission	spectra	of	a	solution	containing	EB	bound	to	CT‐DNA	
may	 be	 used	 to	 study	 the	 interaction	 between	 CT‐DNA	 and	
other	compounds,	such	as	metal	complexes,	since	the	addition	
of	 a	 compound,	 capable	 to	 intercalate	 to	 CT‐DNA	 equally	 or	
more	strongly	than	EB,	could	result	in	a	quenching	of	the	EB‐
CT‐DNA	 fluorescence	 emission	 [64].	 Steady‐state	 competitive	
binding	experiments	using	complexes	1‐4	were	undertaken	to	
get	further	proof	for	the	binding	of	the	complexes	to	DNA.	The	
displacement	 technique	 is	 based	 on	 the	 decrease	 of	 EB	
fluorescence	 resulting	 from	 the	 competitive	 displacement	 of	
EB	 from	a	CT‐DNA	groove	by	 a	 compound	 that	 competes	 for	
the	same	site.	
The	 fluorescence	 quenching	 curves	 of	 EB	 bound	 to	 CT‐
DNA	by	the	reported	complexes	is	shown	in	Figure	4.		
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Figure	3.	Absorption	spectra	of	M(II)	complexes	1‐4	(25	μM)	in	the	absence	
and	presence	of	increasing	amounts	of	CT‐DNA.	Conditions:	[Complex	=	25	
μM,	 [CT‐DNA]	 =	 0‐50	 μM.	 Arrow	 (↓)	 shows	 the	 absorbance	 changes	 upon	
increasing	CT‐DNA	concentration.	Inset:	linear	plot	for	the	calculation	of	the	
intrinsic	CT‐DNA	binding	constant	(Kb).	
	
	
Figure	4. Emission	spectra	of	EB‐CT‐DNA	system	in	absence	and	presence	
of	different	M(II)	complexes	1‐4.	An	arrow	indicates	the	emission	intensity	
changes	 upon	 increasing	 complex	 concentrations.	 Inset:	 Stern‐Volmer	
quenching	curves.	
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As	 it	 is	 shown,	 the	 addition	 of	 complexes	 to	 CT‐DNA	
pretreated	 with	 EB	 causes	 appreciable	 reduction	 in	 the	
emission	intensity,	indicating	that	the	EB‐CT‐DNA	fluorophore	
is	partially	replaced	by	the	reported	complexes.	Furthermore,	
the	 Stern‐Volmer	 plots	 of	 EB‐CT‐DNA	 (Figure	 4	 insets)	
illustrate	 that	 the	 quenching	 of	 EB	 bound	 to	 CT‐DNA	 by	 the	
complexes	 is	 in	 good	 agreement	 (R	 =	 0.99)	 with	 the	 linear	
Stern‐Volmer	 equation	 (Equation	 2)	 [65,66],	 which	 also	
indicates	 that	 the	 complexes	bind	 to	CT‐DNA.	The	KSV	 values	
(Stern‐Volmer	 constant)	 obtained	 by	 Stern‐Volmer	 plots	 of	
DNA‐EB	 are	 (3.39±0.13)	 ×104	 M‐1,	 (2.36±0.05)	 ×104	 M‐1,	
(1.40±0.05)×105	 M‐1	 and	 (1.45±0.02)×104	 M‐1,	 respectively,	
which	suggests	that	the	interaction	of	complexes	with	CT‐DNA	
is	a	moderate	intercalative	mode	following	the	order	3	>	1	>	2	
>	4.	
To	further	clarify	the	interactions	between	the	compounds	
and	 CT‐DNA,	 viscosity	 measurements	 were	 carried	 out.	
Viscosity	measurements	that	are	sensitive	to	length	change	are	
regarded	as	the	least	ambiguous	and	the	most	critical	tests	of	
binding	model	 in	 solutions	 in	 the	absence	of	 crystallographic	
structural	 data.	 The	 viscometric	 measurement	 is	 also	 an	
important	 tool	 to	 find	 the	 nature	 of	 binding	 of	 metal	
complexes	 to	 the	 CT‐DNA.	 A	 classical	 intercalation	 model	
results	in	the	lengthening	of	the	CT‐DNA	helix	as	the	base	pairs	
is	separated	to	accommodate	the	binding	molecule,	leading	to	
an	 increase	 in	 the	 CT‐DNA	 viscosity.	 However,	 a	 partial	 and	
non‐classical	 intercalation	may	 bend	 (or	 kink)	 CT‐DNA	helix,	
resulting	 in	 the	 decrease	 of	 its	 effective	 length	 and	
concomitantly	its	viscosity	[67].	The	relative	specific	viscosity	
of	CT‐DNA	 is	determined	by	varying	 the	concentration	of	 the	
added	compounds.	The	plots	of	(η/ηo)1/3	versus	R,	(where	R	=	
[Compound]/[CT‐DNA]	 (Figure	 5)	 give	 a	 measure	 of	 the	
viscosity	changes.	As	shown	in	Figure.5,	 the	relative	viscosity	
of	 CT‐DNA	 double	 helix	 exhibited	 an	 increase	 as	 a	 result	 of	
intercalation,	 suggesting	 primarily	 groove	 binding	 nature	 of	
the	 complexes.	 Groove	 (or)	 surface	 binding	 can	 cause	 an	
increase	 in	 the	 effective	 length	 of	 DNA	 leading	 to	 a	 minor	
increase	in	the	effective	length	of	CT‐DNA	solution	[68].	
	
 
 
Figure	5.	Effect	of	increasing	amounts	of	ATBD	and	its	M(II)	complexes	1‐4	
on	 the	 on	 the	 relative	 viscosities	 of	 CT‐DNA	 at	 room	 temperature	 (R	 =	
[Complex]/[CT‐DNA]).	
	
3.5.3.	Evaluation	of	radical	scavenging	ability	
	
Schiff	 base	 metal	 complexes	 are	 known	 to	 show	 various	
biological	 activities	 including	 biocidal	 and	 antioxidant	
activities	 [69,70].	 In	view	of	 this	 and	significant	DNA	binding	
affinity	shown	by	 the	 reported	Schiff	base	complexes	used	 in	
the	 present	 study,	 it	 is	 considered	 worthwhile	 to	 study	 the	
antioxidant	 properties	 of	 these	 compounds.	 Reactive	 oxygen	
species	(ROS)	e.g.	superoxide	(O2−•)	and	hydroxyl	(HO•)	radical	
are	 responsible	 for	 the	 disintegration	 of	 cell	 membrane	 and	
damage	to	protein	and	DNA	structures.	As	shown	in	Figure	6a,	
increasing	 concentration	 (5‐25	 μM)	 of	 all	 the	 complexes	
showed	 increasing	 inhibitory	 activities	 against	 ROS.	 Among	
the	 studied	 complexes,	 Cu(II)	 complex	 and	 Co(II)	 complexes	
showed	 highest	 superoxide	 scavenging	 ability	 of	 97%	 and	
80%	 respectively,	 in	 contrast	 to	 70%	 and	 66	 %	 inhibition	
obtained	 in	 case	 of	Ni(II)	 and	Zn(II)	 complexes	 at	 a	 concent‐
ration	of	25	μM.	Moreover,	the	ATBD	Schiff	base	and	its	metal	
complexes	 at	 the	 same	 concentration	 (5‐25	 μM)	 were	 also	
screened	for	the	HO•	radical	scavenging	activity	(Figure	6b).	It	
is	 evident	 from	 the	 results	 that	 both	 Cu(II)	 and	 Co(II)	
complexes	are	better	scavenging	agents	(87%	and	74%)	than	
Ni(II)	 and	 Zn(II)	 complexes,	 which	 showed	 53	 and	 50%	
scavenging	activities	respectively	at	a	concentration	of	25	μM.	
This	trend	can	be	correlated	with	the	fact	that	Cu(II)	and	Co(II)	
complexes	have	 shown	stronger	CT‐DNA	binding	ability	 than	
Ni(II)	and	Zn(II)	complexes.	
	
	
	
	
Figure	6.	Scavenging	effect	of	ATBD	Schiff	base	and	its	complexes	1‐4 on	(a)	
superoxide	radical	and	(b)	hydroxyl	radical.	
	
The	 scavenging	 activities	 of	 ATBD	 and	 its	 complexes	1‐4	
against	 both	 superoxide	 and	 hydroxyl	 radicals	 are	 listed	 in	
Table	 2	 and	 3.	 The	 IC50	 values	 indicated	 that	 the	 reported	
compounds	showed	antioxidant	activity	in	the	order	of	3	>	1	>	
2	>	4	>	ATBD	in	all	the	experiments	(Figure	7).	
	
4.	Conclusion	
	
In	the	present	work,	four	mononuclear	M(II)	complexes	(M	
=	Co,	Ni,	Cu	and	Zn)	of	potentially	tetradentate	N2S2	Schiff	base	
namely:	 N,N'‐bis‐(2‐aminothiophenol)benzene‐1,2‐dicarbox	
aldehyde	 have	 been	 synthesized	 and	 characterized	 by	
physicochemical	and	spectroscopic	methods.		
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Table	2.	The	scavenging	activities	of	Schiff	base	(ATBD)	and	its	complexes	1‐4	against	superoxide	radical.	
Compound	 %	Superoxide	scavenging	activity	(O2−•)		 Equation	 IC50	(μM)	 r2	
5	μM	 10	μM	 15	μM 20	μM 25	μM 	
ATBD	 7.64	 20.58	 34.99	 43.33	 54.66	 y	=	66.13x	‐	41.48	 24.17	 0.969	
[C20H14N2S2Co]	(1)	 25.55	 44.44	 55.65	 64.44	 74.89	 y	=	68.55x	‐	23.42	 11.77	 0.991	
[C20H14N2S2Ni]	(2)	 22.22	 36.55	 46.33 53.22 63.54 y	=	56.79x	‐ 18.94 16.36	 0.981
[C20H14N2S2Cu]	(3)	 43.33	 69.44	 84.66 93.44 98.01 y	=	79.90x	‐ 11.3 5.85	 0.993
[C20H14N2S2Zn]	(4)	 13.33	 27.55	 40.99 47.66 59.33 y	=	63.93x	‐ 33.49 20.22	 0.976
	
	
Table	3.The	scavenging	activities	of	Schiff	base	(ATBD)	and	its	complexes	1‐4	against	hydroxyl	radical.	
Compound	 %	Hydroxyl	scavenging	activity	(HO•)	 Equation	 IC50	(μM)	 r2	
5	μM	 10	μM	 15	μM 20	μM 25	μM
ATBD	 6.77	 18.55	 27.33	 35.55	 41.44	 y	=	49.50x	‐	29.25	 39.90	 0.986	
[C20H14N2S2Co]	(1)	 14.43	 35.41	 56.88	 65.54	 74.43	 y	=	87.62x	‐	48.34	 13.25	 0.990	
[C20H14N2S2Ni]	(2)	 12.32	 25.42	 37.64 43.29 53.28 y	=	56.21x	‐ 28.48 24.89	 0.985
[C20H14N2S2Cu]	(3)	 22.22	 46.44	 62.39 76.59 87.69 y	=	93.01x	‐ 44.63 10.41	 0.993
[C20H14N2S2Zn]	(4)	 11.11	 23.31	 30.86 38.88 74.11 y	=	49.8x	‐ 25.26 32.45	 0.976
	
	
	
	
Figure	7.	 Radical	 scavenging	 activity	 of	 Schiff	 base	 (ATBD)	 and	 its	 metal	
complexes	1‐4.	
	
The	 spectral	 data	 showed	 that	 the	 Schiff	 base	 act	 as	 a	
tetradentate	 ligand	 by	 bonding	 to	 the	metal	 ion	 through	 the	
deprotonated	 thiol‐S	 groups	 and	 azomethine	 nitrogen	 atoms.	
The	 binding	 properties	 of	 the	 complexes	with	 CT‐DNA	were	
examined	by	various	 techniques,	 and	 the	 results	 suggest	 that	
the	 investigated	compounds	bind	to	CT‐DNA	via	 intercalation	
mode.	 Moreover,	 the	 binding	 constants	 showed	 that	 the	
complexes	 have	 a	 higher	 binding	 affinity	 than	 their	 parent	
ligand.	 In	 view	 of	 significant	 DNA	 binding	 affinity	 observed,	
the	 antioxidant	 properties	 of	 these	 compounds	 were	
considered	 worthwhile	 to	 study.	 The	 results	 show	 that,	 the	
complexes	show	stronger	antioxidant	activities	than	the	ligand	
alone	with	highest	activity	in	case	of	Cu(II)	complex.	In	view	of	
the	 data	 obtained,	 the	 novel	 complexes	 would	 be	 helpful	 to	
understand	the	 interaction	mechanism	of	 the	complexes	with	
CT‐DNA	and	are	promising	therapeutic	drug	candidates.	
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